.png)
NORML News: Medical Cannabis Research, Public Opinion and 22 New Florida Licenses
What is happening in cannabis research, public opinion and Florida’s medical marijuana program?
In this edition of NORML News from The Rotation by Suncoast NORML, we examine four stories that deserve more attention: a British study involving medical cannabis and inflammatory arthritis, an international survey of people with eating disorders, new polling about how Americans view cannabis, and Florida’s approval of 22 new Medical Marijuana Treatment Center licenses.
Watch the NORML News segment below, then continue reading for summaries and links to each complete story.
Watch This Week’s NORML News
This segment is presented for educational purposes. Research findings discussed below should not be interpreted as personal medical advice. Patients should consult qualified healthcare professionals before beginning, stopping or changing any treatment.
This Week’s Cannabis News Headlines
Medical cannabis patients with inflammatory arthritis reported lasting improvements in pain, sleep and quality of life.
Many survey respondents with eating disorders reported using cannabis and experiencing symptom relief, although results differed by diagnosis.
A national poll found that most American adults do not consider cannabis particularly dangerous to health.
Florida approved 22 new medical cannabis licenses, but the state may still be behind on licenses required by patient growth.
Study Links Medical Cannabis to Lasting Improvements for Inflammatory Arthritis Patients
New observational research from the United Kingdom offers encouraging evidence about medical cannabis and inflammatory arthritis-associated pain.
Researchers assessed 192 patients enrolled in the UK Medical Cannabis Registry. Participants used prescribed cannabis-based medical products that included cannabis flower, oil extracts and topical preparations. Researchers tracked patient-reported outcomes after one, three, six, 12, 18 and 24 months.
Patients reported improvements in pain-specific measures at every follow-up period. They also reported better sleep and health-related quality of life. Fewer than 15% of participants reported adverse events, which were generally mild and included fatigue and dry mouth.
These findings are promising, particularly for patients whose chronic symptoms have not responded adequately to conventional medications. However, the study was observational—not a randomized, placebo-controlled clinical trial. It can identify meaningful patterns in real-world patient outcomes, but it cannot prove that cannabis alone caused the improvements.
The researchers called for randomized clinical trials to more rigorously evaluate the safety and effectiveness of cannabis-based medicines for inflammatory arthritis pain.
Read the complete story: Study Links Medical Cannabis to Lasting Improvements for Inflammatory Arthritis Patients
Survey: Patients With Eating Disorders Frequently Report Benefits From Cannabis
An international survey published in the Journal of Eating Disorders examined cannabis use among more than 5,300 respondents living with diagnosed eating disorders or disordered eating.
More than half of the respondents reported using cannabis during the previous year, while more than 40% of cannabis consumers reported daily use. Cannabis flower was the most commonly reported preparation.
Many participants—particularly those living with anorexia nervosa or avoidant/restrictive food intake disorder—associated cannabis with improvements in symptoms such as food anxiety, nausea and difficulty eating. Respondents generally rated cannabis positively compared with the prescription and non-prescription drugs assessed by the survey.
The findings were not positive for everyone. Participants with binge eating disorder were more likely to report that cannabis worsened certain symptoms. Some respondents also expressed concerns about problematic cannabis use.
This distinction is important: eating disorders are complex medical and mental-health conditions, and a substance perceived as helpful by one group may be ineffective or counterproductive for another. Because the study relied on self-reported survey data, it does not establish cannabis as a proven treatment.
What it does show is that cannabis use is already common among people with eating disorders and that controlled clinical research into THC- and CBD-containing products is warranted.
Read the complete story: Survey: Patients With Eating Disorders Frequently Report Benefits From Cannabis
Poll: Most Americans Say Cannabis Is Not Particularly Dangerous to Health
The gap between federal cannabis policy and American public opinion continues to grow.
According to nationwide polling from Rasmussen Reports, 55% of American adults said cannabis is either “not very dangerous” or “not dangerous at all.” Only 13% characterized it as very dangerous.
The poll also identified a partisan divide. Republican respondents were more likely than Democratic respondents to consider cannabis dangerous and to accept the idea that it acts as a so-called gateway drug.
These results do not mean that cannabis is harmless or appropriate for everyone. Cannabis can present risks, especially for adolescents, people with certain health conditions and anyone who drives or operates machinery while impaired. The findings instead suggest that most Americans no longer accept the exaggerated portrayal of cannabis that helped sustain prohibition for generations.
That changing perception matters. Public attitudes influence elections, legislation, research priorities and whether criminal penalties continue to be viewed as a reasonable response to cannabis use.
Evidence-based policy can acknowledge potential risks while also recognizing the damage caused by arrests, criminal records and unequal enforcement. Education, testing, responsible regulation and honest public-health information offer a better path than fear-based messaging.
Read the complete story: Poll: Most Americans Say Cannabis Is Not Particularly Dangerous to Health
Florida Approves 22 New Medical Cannabis Licenses—but the State May Still Owe Patients More
Florida has approved 22 new Medical Marijuana Treatment Center licenses following an application process that began more than three years ago.
An MMTC license permits a vertically integrated operator to cultivate, process and dispense medical marijuana within Florida’s regulated program. More licensed operators could eventually mean additional dispensaries, greater product selection, increased competition and improved access for patients.
But approval does not mean that 22 new businesses can immediately begin serving patients.
New license holders face substantial financial and operational requirements. These reportedly include posting a $5 million financial-assurance bond within 10 business days, requesting cultivation authorization within 180 days, processing authorization within 270 days and dispensing authorization within 365 days.
The larger question is whether these 22 licenses bring Florida into compliance with its own licensing formula.
Florida law links the number of MMTC licenses to growth in the medical marijuana patient population. With more than 941,000 active patients participating in the program, the state may still be behind on the number of licenses it is required to issue.
Florida patients deserve a licensing process that is transparent, timely and focused on access. State regulators should clearly explain how many licenses are currently required, whether additional licenses remain outstanding and when the next application period will begin.
Twenty-two approvals represent movement. They should not automatically be mistaken for a completed job.
Read the complete story: Florida Approves 22 New Medical Cannabis Licenses—but the State May Still Owe Patients More
Why These Cannabis Stories Matter
Although these four reports address different subjects, they point toward the same larger reality: cannabis policy must catch up with evidence and lived experience.
Patients are already using cannabis-based products to manage difficult symptoms. Researchers are identifying outcomes that deserve controlled clinical trials. Most Americans no longer view cannabis through the lens of “Reefer Madness.” Meanwhile, Florida’s medical marijuana program continues to struggle with a slow, expensive and highly restricted licensing process.
Good cannabis policy should not be based on exaggeration from either side. It should be built on rigorous research, honest education, patient access, sensible regulation and accountability from public officials.
That is why Suncoast NORML continues to cover the research, laws and political decisions shaping cannabis policy in Florida and across the country.
Watch the Full Episode of The Rotation
The NORML News segment is only one part of the conversation. Watch the complete episode of The Rotation by Suncoast NORML below for the full discussion, guest interview and additional cannabis-industry and policy analysis.
The Rotation brings patients, advocates, candidates, researchers and cannabis-industry leaders into direct conversations about legalization, criminal justice, medical access and the future of the movement.
Watch more episodes and learn about upcoming guests at The Rotation by Suncoast NORML.
Stay Informed and Get Involved
Cannabis laws do not change by themselves. Research, public education, voter participation and sustained advocacy all matter.
Follow Suncoast NORML for additional cannabis news, medical research, Florida policy updates and new episodes of The Rotation. If you believe cannabis laws should be grounded in evidence rather than stigma, consider becoming a member and helping us continue the work of NORMLizing the conversation.
Frequently Asked Questions
What is NORML News?
NORML News is a recurring segment from The Rotation by Suncoast NORML. It summarizes important developments in cannabis research, public opinion, law and public policy.
What did the inflammatory arthritis study find?
Patients enrolled in the UK Medical Cannabis Registry reported improvements in pain, sleep and quality of life across multiple follow-up periods. Because the research was observational, randomized clinical trials are still needed to determine effectiveness.
Does cannabis treat eating disorders?
Cannabis is not established as a universal treatment for eating disorders. Many survey respondents reported perceived benefits, especially those with restrictive or food-averse conditions, while some people with binge eating disorder reported worsened symptoms. Anyone experiencing an eating disorder should seek qualified medical and mental-health care.
Do most Americans believe cannabis is dangerous?
In the Rasmussen Reports poll discussed in this segment, 55% of respondents said cannabis was not very dangerous or not dangerous at all. Thirteen percent considered it very dangerous.
How many new medical cannabis licenses did Florida approve?
Florida approved 22 new Medical Marijuana Treatment Center licenses. Questions remain about how quickly the new licensees can become operational and whether Florida is still behind on licenses connected to patient-population growth.
Where can I watch The Rotation?
Episodes, guest information and show updates are available through The Rotation page on Suncoast NORML.
This article is intended for educational and informational purposes only. It does not constitute medical or legal advice.
Comments